UP Philippine General Hospital Division of Endocrinology, diabetes & metabolism consensus recommendations for in-patient management of diabetes mellitus among persons with COVID-19 / (Record no. 2321)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02105nam a22002777a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DOH |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20210109104153.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 210109b ||||| |||| 00| 0 eng d |
| 245 00 - TITLE STATEMENT | |
| Title | UP Philippine General Hospital Division of Endocrinology, diabetes & metabolism consensus recommendations for in-patient management of diabetes mellitus among persons with COVID-19 / |
| Remainder of title | Cecilia Jimeno [and seven others] |
| 520 3# - SUMMARY, ETC. | |
| Summary, etc. | Diabetes mellitus (DM) is a known risk factor for morbidity and mortality among patients with COVID-19 based on recent<br/>studies. While there are many local and international guidelines on inpatient management of diabetes, the complicated<br/>pathology of the virus, the use of glucose-elevating drugs such as glucocorticoids, antivirals and even inotropes, and<br/>various other unique problems has made the management of in-hospital hyperglycemia among patients with COVID-19<br/>much more difficult than in other infections. The objective of this guidance is to collate and integrate the best available<br/>evidence that has been published regarding in-patient management of diabetes among patients with COVID-19.<br/>A comprehensive review of literature was done and recommendations have been made through a consensus of expert<br/>endocrinologists from the University of the Philippines-Philippine General Hospital (UP-PGH) Division of Endocrinology,<br/>Diabetes and Metabolism. These recommendations are evolving as we continue to understand the pathology of the<br/>disease and how persons with diabetes are affected by this virus. |
| 580 ## - LINKING ENTRY COMPLEXITY NOTE | |
| Linking entry complexity note | In: JAFES 2020; vol. 35 (1) pages: 14-25 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | COVID-19 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Diabetes Mellitus |
| 653 ## - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | In-patient Management |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jimeno, Cecilia |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Anonuevo-Cruz, Ma. Cecille |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bea Uy, Angelique |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bacena, Adrian Oscar |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Francisco, Mark David |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tiglao-Gica, Angelique Love |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bruno, Racquel |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Corpuz, Diane Grace |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://www.asean-endocrinejournal.org/index.php/JAFES/article/view/821">https://www.asean-endocrinejournal.org/index.php/JAFES/article/view/821</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | COVID 19 Resource |
| 999 ## - | |
| -- | 2321 |
| -- | 2321 |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Shelving location | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| National Library of Medicine | DOH Central Library | DOH Central Library | Electronic Resource Section | 01/09/2021 | COVID-19-000087 | D0001C000087 | 01/09/2021 | 01/09/2021 | COVID 19 Resource |